Skip to main content

stock

ERNA · Ernexa Therapeutics Inc.

What Ernexa Therapeutics Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live ERNA price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ERNA.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
1,632,411 as of 2026-08-06 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
83.5%
Operating
—
Net
—

Returns

ROE
-383.1%
ROA
-194.1%

Health

Current ratio
2.0x
Debt/equity
—

Deep value

NCAV
$2.78M
NCAV per share
$1.70
Price/NCAV
Locked
NNWC
$1.91M
NNWC per share
$1.17
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30——-$4.10M-$4.01M
10-Q filed 2026-08-06
2026-03-31——-$5.59M-$5.51M
10-Q filed 2026-05-11
2025-12-31——-$2.10M-$1.50M
DEF 14A filed 2026-05-11
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30——-$1.99M-$1.24M
10-Q filed 2025-11-07
2025-06-30——-$2.50M-$3.14M
10-Q filed 2026-08-06
2025-03-31——-$2.73M-$8.20M
10-Q filed 2026-05-11
2024-12-31$1,000$1,000-$2.70M-$5.76M
DEF 14A filed 2026-05-11
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$487,000$547,000-$2.26M-$26.60M
10-Q filed 2025-11-07
Assets
$6.32M
Equity
$3.20M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$9.32M-$14.08M-$7.05M
2024-12-31$582,000-$15.67M-$44.54M-$16.20M
2023-12-31$68,000-$21.14M-$21.67M-$20.43M
2022-12-31$0-$33.22M-$24.58M-$21.27M
2021-12-31—-$113.73M-$122.55M-$23.64M
2020-12-31$5.80M-$7.25M-$7.29M-$8.14M
2019-12-31$19.81M-$1.76M-$2.05M$2.62M
2018-12-31$23.34M$203,000-$259,000$717,000
2017-12-31$21.27M-$1.40M-$1.08M-$179,000
2016-12-31$22.31M-$2.28M-$2.92M-$404,000

Company filings

since Tue Mar 24 · 1 offering filing in 12 months

events

  • Regulation FD disclosure

    Regulation FD disclosure
    Sep 168-K
  • Executive or director change

    Executive or director change
    Sep 168-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Jul 28-K
  • Shareholder vote results

    Shareholder vote results
    Jul 28-K
  • Executive or director change

    Executive or director change
    Jun 268-K
  • Bylaws or fiscal year change

    Bylaws or fiscal year change
    May 48-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ERNA, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ERNA.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ERNA.

nakagai

Signals on ERNA come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ERNA board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Ernexa Therapeutics Inc. (ERNA): SEC filings, financials and insider trades · Nakagai